Octapharma AG: European Commission Adopts European Medicines Agency’s (EMA) Recommendation to Lift the Suspension of the Marketing Authorization of octagam(R) and octagam(R)10%

On 30 May 2011 The European Commission adopted the EMA’s recommendation of 14 April 2011 revised on May 12, 2011 to lift the suspension of the marketing authorization of octagam® and octagam®10%, thus allowing both products back on the European markets.